Biotech

All Articles

Novartis pens $150M upfront bispecifics handle Dren Bio

.Novartis has possessed some rotten luck with bispecific antitoxins before, however evaluating due t...

AstraZeneca plants an EGFR plant along with Pinetree offer worth $45M

.Pinetree Therapeutics are going to help AstraZeneca plant some plants in its pipe along with a bran...

GRO rounds up $60M collection B to take gout pain treatment into clinic

.GRO Biosciences has ended the week with an added $60.3 million in the bank, which the protein thera...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops CEO

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings...